Zotepine for schizophrenia

Effect of zotepine on fenfluramine-induced hyperthermia in rats.

Zotepine for behavioural and psychological symptoms in dementia: an open-label study.

OBJECTIVE To provide initial information on the safety and efficacy of the atypical antipsychotic zotepine in the treatment of behavioural and psychological symptoms of dementia (BPSD). METHODS This was an open-label, single-centre field study. Twenty-four patients with BPSD associated with Alzheimer's disease (n=12) or other forms of dementia (n=12) were included. During the 8-week observati...

Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol.

BACKGROUND AND PURPOSE Zotepine is claimed to be a neuroleptic drug with atypical features. However, there have been few double-blind studies in Asian patients. The purpose of this study was to compare the efficacy and safety of zotepine and haloperidol in Taiwanese patients with schizophrenia. PATIENTS AND METHODS Patients with positive symptoms (n = 70) were enrolled into this double-blind,...

Minimum data set for electronic health card of schizophrenia

Purpose: Having a clinical information system is a good solution for monitoring medical problems. This system is designed to improve the speed and accuracy of data management. The goal is to replace medical records with a clinical information system to support storing, processing and distributing data in all the sections of a healthcare center. The purpose of this research was to determine ...

Evaluation of the Pharmacotherapeutic Pattern for Treating Schizophrenia in Bangladesh

Background: Studies of the pharmacotherapeutic pattern on schizophrenic patients are few clinical therapy is one of the bases for the assessment of the treatment of Schizophrenia. Objectives: This study aimed to analyze the demographics of these patients along with current trends of drug prescribing practice in Bangladesh. Methods: This survey was conducted over 6 months at the National Insti...